Oxytocin and bone

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 307, Issue 8, 2014, Pages R970-R977

  Colaianni, Graziana ^a   Sun, L ^b   Zaidi, Mone ^b   Zallone, Alberta ^a  

^a UNIVERSITY OF BARI   (Italy)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Bone; Estrogen; Hormones; Osteoporosis; Oxytocin

Indexed keywords

ESTRADIOL; ESTROGEN; OXYTOCIN; OXYTOCIN RECEPTOR;

ARTICLE; BIRTH; BONE; BONE MARROW; BONE MASS; ESTROGEN ACTIVITY; HUMAN; HYPOPHYSIS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PROTEIN EXPRESSION; ANIMAL; ANIMAL MODEL; AUTOCRINE EFFECT; BONE DEVELOPMENT; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; AUTOCRINE COMMUNICATION; BONE AND BONES; ESTRADIOL; HUMANS; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OXYTOCIN; RECEPTORS, OXYTOCIN;

EID: 84908072549     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00040.2014     Document Type: Article

References (91)

1. Abe E, Marians RC, Yu W, Wu XB, Ando T, Li Y, Iqbal J, Eldeiry L, Rajendren G, Blair HC, Davies TF, Zaidi M. TSH is a negative regulator of skeletal remodelling. Cell 115: 151-162, 2003.
2. Almeida M, Han L, Martin-Millan M, Plotkin LI, Stewart SA, Roberson PK, Kousteni S, O’Brien CA, Bellido T, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem 282: 27,285-27, 297, 2007.
3. Almeida M, Iyer S, Martin-Millan M, Bartell SM, Han L, Ambrogini E, Onal M, Xiong J, Weinstein RS, Jilka RL, O’Brien CA, Manolagas SC. Estrogen receptorsignaling in osteoblast progenitors stimulates cortical bone accrual. J Clin Invest 123: 394-404, 2013.
4. Armstrong VJ, Muzylak M, Sunters A, Zaman G, Saxon LK, Price JS, Lanyon LE. WNT/B-catenin signaling is a component of osteoblastic bone cells’ early responses to load-bearing, and requires estrogen receptor. J BiolChem 282:20,715-20,727,2007.
5. Baron R, Rawadi G. Targeting the Wnt/-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148: 2635-2643, 2007.
6. Barsony J, Sugimura Y, Verbalis JG. Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss. J Biol Chem 286: 10,864-10,875, 2011.
7. Björkstrand E, Uvnäs-Moberg K. Central oxytocin increases food intake and daily weight gain in rats. Physiol Behav 59: 947-952, 1996.
8. Bredella MA, Torriani M, Ghomi RH, Thomas BJ, Brick DJ, Gerweck AV, Rosen CJ, Klibanski A, Miller KK. Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity (Silver Spring) 19: 49-53, 2011.
9. Breuil V, Amri EZ, Panaia-Ferrari P, Testa J, Elabd C, Albert-Sabonnadière C, Roux CH, Ailhaud G, Dani C, Carle GF, Euller-Ziegler L. Oxytocin and bone remodelling: relationships with neuropituitary hormones, bone status and body composition. Joint Bone Spine 78: 611-615, 2011.
10. Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF. J ClinInvest 106:1229-1327,2000.
11. Chang J, Wang Z, Tang E, Fan Z, McCauley L, Franceschi R, Guan K, Krebsbach PH, Wang CY. Inhibition of osteoblastic bone formation by nuclear factorB. Nat Med 15: 682-689, 2009.
12. Cianferotti L, Demay MB. VDR-mediated inhibition of DKK1 and SFRP2 suppresses adipogenic differentiation of murine bone marrow stromal cells. J Cell Biochem 101: 80-88, 2007.
13. Colaianni G, Cuscito C, Colucci S. FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis. Clin Dev Immunol 2013: 382698, 2013.
14. Colaianni G, Di Benedetto A, Zhu LL, Tamma R, Li J, Greco G, Peng Y, Dell’Endice S, Zhu G, Cuscito C, Grano M, Colucci S, Iqbal J, Yuen T, Sun L, Zaidi M, Zallone A. Regulated production of the pituitary hormone oxytocin from human and murine osteoblasts. Biochem Biophys Res Commun 411: 512-515, 2011.
15. Colaianni G, Sun L, Di Benedetto A, Tam ma R, Zhu LL, Cao J, Grano M, Yuen T, Colucci S, Cuscito C, Mancini L, Li J, Nishimori K, Bab I, Lee HJ, Iqbal J, Young WS, Rosen C, Zallone A, Zaidi M. Bone marrow oxytocin mediates the anabolic action of estrogen on the skeleton. J Biol Chem 287: 29,159-29,167, 2012.
16. Costa-E-Sousa RH, Pereira-Junior PP, Oliveira PF, Werneck-de-Castro JP, Mello DB, Nascimento JH, Campos-de-Carvalho AC. Cardiac effects of oxytocin: is there a role for this peptide in cardiovascular homeostasis? Regul Pept 132: 107-112, 2005.
17. De Dreu CKW, Greer LL, Van Kleef GA, Shalvi S, Handgraaf MJJ. Oxytocin promotes human ethnocentrism. Proc Natl Acad Sci USA 108: 1262-1266, 2011.
18. Deblon N, Veyrat-Durebex C, Bourgoin L, Caillon A, Bussier AL, Petrosino S, Piscitelli F, Legros JJ, Geenen V, Foti M, Wahli W, Di Marzo V, Rohner-Jeanrenaud. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One 6: e25565, 2011.
19. Di Iorgi N, Mittelman SD, Gilsanz V. Differential effect of marrow adiposity and visceral and subcutaneous fat on cardiovascular risk in young, healthy adults. Int J Obes (Lond) 32: 1854-1860, 2008.
20. Ditzen B, Schaer M, Gabriel B, Bodenmann G, Ehlert U, Heinrichs M. Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biol Psychiatry 65: 728-731, 2009.
21. Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111: 1221-1230, 2003.
22. Elabd C, Basillais A, Beaupied H, Breuil V, Wagner N, Scheideler M. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis. Stem Cells 26: 2399-2407, 2008.
23. Emerton KB, Hu B, Woo AA, Sinofsky A, Hernandez C, Majeska RJ, Jepsen KJ, Schaffler MB. Osteocyte apoptosis and control of bone resorption following ovariectomy in mice. Bone 46: 577-583, 2010.
24. Evans JJ, Forrest-Owen W, McArdle CA. Oxytocin receptor-mediated activation of phosphoinositidase C and elevation of cytosolic calcium in the gonadotrope-derived T3-1 cell line. Endocrinology 138: 2049-2055, 1997.
25. Galea GL, Meakin LB, Sugiyama T, Zebda N, Sunters A, Taipaleenmaki H, Stein GS, van Wijnen AJ, Lanyon LE, Price JS. Estrogen receptor mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor. J Biol Chem 288: 9035-9048, 2013.
26. Gao Y, Grassi F, Ryan MR, Terauchi M, Page K, Yang X, Weitzmann MN, Pacifici R. IFNstimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest 117: 122-132, 2007.
27. Griffith JF, Yeung DK, Antonio GE, Lee FK, Hong AW, Wong SY, Lau EM, Leung PC. Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy. Radiology 236: 945-951, 2005.
28. Gutkowska J, Jankowski M, Lambert C, Mukaddam-Daher S, Zingg HH, McCann SM. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci USA 94: 11704-11709, 1997.
29. Heinrichs M, Baumgartner T, Kirschbaum C, Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry 54: 1389-1398, 2003.
30. Hobo S, Hayashida K, Eisenach JC. Oxytocin inhibits the membrane depolarization-induced increase in intracellular calcium in capsaicin sensitive sensory neurons: a peripheral mechanism of analgesic action. Anesth Analg 114: 442-449, 2012.
31. Holder JL, Jr., Butte NF, Zinn AR. Profound obesity associated with a balanced translocation that disrupts the sim1 gene. Hum Mol Genet 9: 101-108, 2000.
32. Imai Y, Bonewald LF, Kondoh S, Kato S. Estrogen receptor alpha expression in osteocytes is necessary to maintain normal bone mineral density and reduce bone loss due to unloading (Abstract). J Bone Miner Res. 26 Suppl 1, 2011.
33. Inoue T, Kimura T, Azuma C, Inazawa J, Takemura M, Kikuchi T, Kubota Y, Ogita K, Saji F. Structural organization of the human oxytocin receptor gene. J Biol Chem 269: 32451-32456, 1994.
34. Isales CM, Zaidi M, Blair HC. ACTH is a novel regulator of bone mass. Ann NY Acad Sci 1192: 110-116, 2010.
35. Jankowski M, Danalache B, Wang D, Bhat P, Hajjar F, Marcinkiewicz M, Paquin J, McCann SM, Gutkowska J. Oxytocin in cardiac ontogeny. Proc Natl Acad Sci USA 101: 13074-13079, 2004.
36. Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E. Oxytocinincreases trust in humans. Nature 435: 673-676, 2005.
37. Kousteni S, Bellido T, Plotkin LI, O’Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104: 719-730, 2001.
38. Kovacs CS. Calcium and bone metabolism in pregnancy and lactation. J Clin Endocrinol Metab 86: 2344-2348, 2001.
39. Kovacs CS, Kronenberg HM. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium and lactation. Endocr Rev 18: 832-872, 1997.
40. Krause C, Korchynskyi O, de Rooij K, Weidauer SE, de Gorter DJ, van Bezooijen RL, Hatsell S, Economides AN, Mueller TD, Löwik CW, ten Dijke P. Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. J Biol Chem 285: 41,614-41,626, 2010.
41. Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest 116: 1202-1209, 2006.
42. Kublaoui BM, Gemelli T, Tolson KP, Wang Y, Zinn AR. Oxytocin deficiency mediates hyperphagic obesity of sim1 haploinsufficient mice. Mol Endocrinol 22: 1723-1734, 2008.
43. Lawson EA, Ackerman KE, Estella NM, Guereca G, Pierce L, Sluss PM, Bouxsein ML, Klibanski A, Misra M. Nocturnal oxytocin secretion is lower in amenorrheic athletes than nonathletes and associated with bone microarchitecture and finite element analysis parameters. Eur J Endocrinol 168: 457-464, 2013.
44. Lawson EA, Donoho DA, Blum JI, Meenaghan EM, Misra M, Herzog DB, Sluss PM, Miller KK, Klibanski A. Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. J Clin Psychiatry 72: 1546-1551, 2011.
45. Lee HJ, Caldwell HK, Macbeth AH, Tolu SG, Young WS. A conditional knockout mouse line of the oxytocin receptor. Endocrinology 149: 3256-3263, 2008.
46. Lee SK, Kadono Y, Okada F, Jacquin C, Koczon-Jareml B, Adams DJ, Aguila HL, Choi Y, Lorenzo JA. T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. J Bone Miner Res 21: 1704-1712, 2006.
47. Li X, Ominsky MS, Niu QT, Sun N, Daugherty B, D’Agostin D, Kurahara C, Gao Y, Cao J, Gong J, Asuncion F, Barrero M, Warmington K, Dwyer D, Stolina M, Morony S, Sarosi I, Kostenuik PJ, Lacey DL, Simonet WS, Ke HZ, Paszty C. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 23: 860-869, 2008.
48. Li X, Ominsky MS, Warmington KS, Morony S, Gong J, Cao J, Gao Y, Shalhoub V, Tipton B, Haldankar R, Chen Q, Winters A, Boone T, Geng Z, Niu QT, Ke HZ, Kostenuik PJ, Simonet WS, Lacey DL, Paszty C. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res 24: 578-588, 2009.
49. Liu X, Shimono K, Zhu LL, Li J, Peng Y, Imam A, Iqbal J, Moonga S, Colaianni G, Su C, Lu Z, Iwamoto M, Pacifici M, Zallone A, Sun L, Zaidi M. Oxytocin deficiency impairs maternal skeletal remodeling. Biochem Biophys Res Commun 388: 161-166, 2009.
50. Maejima Y, Iwasaki Y, Yamahara Y, Kodaira M, Sedbazar U, Yada T. Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass. Aging 3: 1169-1177, 2011.
51. Manolagas SC, Kousteni S, Jilka RL. Sex steroids and bone. Recent Prog Horm Res 57: 385-409, 2002.
52. Menagh PJ, Turner RT, Jump DB, Wong CP, Lowry MB, Yakar S, Rosen CJ, Iwaniec UT. Growth hormone regulates the balance between bone formation and bone marrow adiposity. J Bone Miner Res 25: 757-768, 2010.
53. Mirza FS, Padhi ID, Raisz LG, Lorenzo JA. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. J Clin Endocrinol Metab 95: 1991-1997, 2010.
54. Mödder UIL, Clowes JA, Hoey K, Peterson JM, McCready L, Oursler MJ, Riggs BL, Khosla S. Regulation of circulating sclerostin levels by sex steroids in women and men. J Bone Miner Res 26: 27-34, 2011.
55. Murata T, Narita K, Ichimaru T. Rat uterine oxytocin receptor and estrogen receptor and mRNA levels are regulated by estrogen through multiple estrogen receptors. J Reprod Dev Mar 60: 55-61, 2014.
56. Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, Penninger JM, Takayanagi H. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 17: 1231-1234, 2011.
57. Nishimori K, Young LJ, Guo Q, Wang Z, Insel TR, Matzuk MM. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc Natl Acad Sci USA 93: 11,699-11,704, 1996.
58. Nuttall ME, Gimble JM. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 4: 290-294, 2004.
59. Petersson M, Uvnas-Moberg K. Postnatal oxytocin treatment of spontaneously hypertensive male rats decreases blood pressure and body weight in adulthood. Neurosci Lett 440: 166-169, 2008.
60. Phaneuf S, Carrasco MP, Europe-Finner GN, Hamilton CH, López Bernal A. Multiple G proteins and phospholipase C isoforms in human myometrial cells: implication for oxytocin action. J Clin Endocrinol Metab 81: 2098-2103, 1996.
61. Qin J, Feng M, Wang C, Ye Y, Wang PS, Liu C. Oxytocin receptor expressed on the smooth muscle mediates the excitatory effect of oxytocin on gastric motility in rats. Neurogastroenterol Motil 21: 430-438, 2009.
62. Ritchi LD, Fung EB, Halloran BP, Turnland JR, VanLoan MD, Cann CE, King JC. A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. Am J Clin Nutr 76: 693-701, 1998.
63. Rodrigues SM, Saslow LR, Garcia N, John OP, Keltner D. Oxytocin receptor genetic variation relates to empathy and stress reactivity in humans. Proc Natl Acad Sci USA 106: 21,437-21,441, 2009.
64. Sass DA, Liss T, Bowman AR, Rucinski B, Popoff SN, Pan Z, Ma YF, Epstein S. The role of the T-lymphocyte in estrogen deficiency osteopenia. J Bone Miner Res 12: 479-486, 1997.
65. Sclafani A, Rinaman L, Vollmer RR, Amico JA. Oxytocin knockout mice demonstrate enhanced intake of sweet and nonsweet carbohydrate solutions. Am J Physiol Regul Integr Comp Physiol 292: R1828-R1833, 2007.
66. Seriwatanachai D, Thongchote K, Charoenphandhu N, Pandaranandaka J, Tudpor K, Teerapornpuntakit J, Suthiphongchai T, Krishnamra N. Prolactin directly enhances bone turnover by raising osteoblastexpressed receptor activator of nuclear factorB ligand/osteoprotegerin ratio. Bone 42: 535-546, 2008.
67. Shevde NK, Bendixen AC, Dienger KM, Pike JW. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci USA 97: 7829-7834, 2000.
68. Sowers M. Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis. J Bone Miner Res 11: 1052-1060, 1996.
69. Sowers M, Eyre D, Hollis DW, Randolph JF, Shapiro B, Jannausch ML, Crutchfield M. Biochemical markers of bone turnover in lactating and nonlactating postpartum women. J Clin Endocrinol Metab 80: 2210-2216, 1995.
70. Sowers M, Jannausch M, McConnell D, Little R, Greendale GA, Finkelstein JS, Neer RM, Johnston J, Ettinger B. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 91: 1261-1267, 2006.
71. Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu LL, Yaroslavskiy BB, Zhou H, Zallone A, Sairam MR, Kumar TR, Bo W, Braun J, Cardoso-Landa L, Schaffler MB, Moonga BS, Blair HC, Zaidi M. FSH directly regulates bone mass. Cell 125: 247-260, 2006.
72. Swaab DF, Purba JS, Hofman MA. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: A study of five cases. J Clin Endocrinol Metab 80: 573-579, 1995.
73. Syed FA, Mödder UI, Roforth M, Hensen I, Fraser DG, Peterson JM, Oursler MJ, Khosla S. Effects of chronic estrogen treatment on modulating age-related bone loss in female mice. J Bone Miner Res 25: 2438-2446, 2010.
74. Tahara M, Morishige K, Sawada K, Ikebuchi Y, Kawagishi R, Tasaka K, Murata Y. RhoA/Rho-kinase cascade is involved in oxytocin-induced rat uterine contraction. Endocrinology 143: 920-929, 2002.
75. Takayanagi Y, Kasahara Y, Onaka T, Takahashi N, Kawada T, Nishimori K. Oxytocin receptor-deficient mice developed late-onset obesity. Neuroreport 19: 951-955, 2008.
76. Tamma R, Colaianni G, Zhu LL, DiBenedetto A, Greco G, Montemurro G, Patano N, Strippoli M, Vergari R, Mancini L, Colucci S, Grano M, Faccio R, Liu X, Li J, Usmani S, Bachar M, Bab I, Nishimori K, Young LJ, Buettner C, Iqbal J, Sun L, Zaidi M, Zallone A. Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci USA 106: 7149-7154, 2009.
77. Tamma R, Sun L, Cuscito C, Lu P, Corcelli M, Li J, Colaianni G, Moonga SS, Di Benedetto A, Grano M, Colucci S, Yuen T, New MI, Zallone A, Zaidi M. Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia. Proc Natl Acad Sci USA 110: 18644-18649, 2013.
78. Tang GY, Lv ZW, Tang RB, Liu Y, Peng YF, Li W, Cheng YS. Evaluation of MR spectroscopy and diffusion-weighted MRI in detecting bone marrow changes in postmenopausal women with osteoporosis. Clin Radiol 65: 377-381, 2010.
79. Thibonnier M, Conarty DM, Preston JA, Plesnicher CL, Dweik RA, Erzurum SC. Human vascular endothelial cells express oxytocin receptors. Endocrinology 140: 1301-1309, 1999.
80. Tolson KP, Gemelli T, Gautron L, Elmquist JK, Zinn AR, Kublaoui BM. Postnatal sim1 deficiency causes hyperphagic obesity and reduced Mc4r and oxytocin expression. J Neurosci 30: 3803-3812, 2010.
81. Tomkinson A, Gevers EF, Wit JM, Reeve J, Noble BS. The role of estrogen in the control of rat osteocyte apoptosis. J Bone Miner Res 13: 1243-1250, 1998.
82. Tomkinson A, Reeve J, Shaw RW, Noble BS. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 82: 3128-3135, 1997.
83. Tsuda T, Ueno Y, Yoshikawa T, Kojo H, Osawa T. Microarray profiling of gene expression in human adipocytes in response to anthocyanins. Biochem Pharmacol 71: 1184-1197, 2006.
84. Urano T, Shiraki M, Ouchi Y, Inoue S. Association of circulating sclerostin levels with fat mass and metabolic disease—related markers in Japanese postmenopausal women. J Clin Endocrinol Metab 97: E1473-E1477, 2012.
85. VanHouten JN, Wysolmerski JJ. Low estrogen and high parathyroid hormone-related peptide levels contribute to accelerated bone resorption and bone loss in lactating mice. Endocrinology 144: 5521-5529, 2003.
86. Vincent BH, Montufar-Solis D, Teng BB, Amendt BA, Schaefer J, Klein JR. Bone marrow cells produce a novel TSH splice variant that is upregulated in the thyroid following systemic virus infection. Genes Immun J 10: 18-26, 2009.
87. Weitzmann MN, Pacifici R. T cells: unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis. Ann NY Acad Sci 1116: 360-375, 2007.
88. Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O’ Brien CA. Matrix-embedded cells control osteoclast formation. Nat Med 17: 1235-1241, 2011.
89. Yu Q, Ji R, Gao X, Fu J, Guo W, Song X, Zhao X, Burnstock G, Shi X, He C, Xiang Z. Oxytocin is expressed by both intrinsic sensory and secretomotor neurons in the enteric nervous system of guinea pig. Cell Tissue Res 344: 227-237, 2011.
90. Zaidi M, Sun L, Robinson LJ, Tourkova IL, Liu L, Wang Y, Zhu LL, Liu X, Li J, Peng Y, Yang G, Shi X, Levine A, Iqbal J, Yaroslavskiy BB, Isales C, Blair HC. ACTH protects against glucocorticoidinduced osteonecrosis of bone. Proc Natl Acad Sci USA 107: 8722-8727, 2010.
91. Zhang G, Cai D. Circadian intervention of obesity development via resting-stage feeding manipulation or oxytocin treatment. Am J Physiol Endocrinol Metab 301: E1004-E1012, 2011.